Precigen Inc (PGEN)
1.335
0.00 (0.00%)
USD |
NASDAQ |
Apr 19, 16:00
1.335
0.00 (0.00%)
After-Hours: 20:00
Precigen Cash from Investing (Quarterly): 13.29M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.29M |
| September 30, 2023 | 10.52M |
| June 30, 2023 | 23.50M |
| March 31, 2023 | -50.41M |
| December 31, 2022 | 11.42M |
| September 30, 2022 | 181.86M |
| June 30, 2022 | 16.57M |
| March 31, 2022 | 16.57M |
| December 31, 2021 | 15.93M |
| September 30, 2021 | 22.01M |
| June 30, 2021 | 16.62M |
| March 31, 2021 | -129.10M |
| December 31, 2020 | 40.18M |
| September 30, 2020 | 0.181M |
| June 30, 2020 | 23.97M |
| March 31, 2020 | -36.55M |
| December 31, 2019 | -4.563M |
| September 30, 2019 | 13.78M |
| June 30, 2019 | -15.03M |
| March 31, 2019 | 33.59M |
| December 31, 2018 | 30.74M |
| September 30, 2018 | -161.03M |
| June 30, 2018 | -13.46M |
| March 31, 2018 | -7.456M |
| Date | Value |
|---|---|
| December 31, 2017 | 23.91M |
| September 30, 2017 | 28.14M |
| June 30, 2017 | 17.73M |
| March 31, 2017 | 34.55M |
| December 31, 2016 | 16.75M |
| September 30, 2016 | -63.77M |
| June 30, 2016 | 14.74M |
| March 31, 2016 | 3.88M |
| December 31, 2015 | -1.927M |
| September 30, 2015 | -239.51M |
| June 30, 2015 | 8.225M |
| March 31, 2015 | -26.03M |
| December 31, 2014 | 10.46M |
| September 30, 2014 | -39.75M |
| June 30, 2014 | -22.60M |
| March 31, 2014 | 25.86M |
| December 31, 2013 | -1.959M |
| September 30, 2013 | -126.39M |
| June 30, 2013 | -95.84M |
| March 31, 2013 | 0.531M |
| December 31, 2012 | -6.539M |
| September 30, 2012 | -0.17M |
| June 30, 2012 | -1.263M |
| March 31, 2012 | -15.66M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-129.10M
Minimum
Mar 2021
181.86M
Maximum
Sep 2022
8.987M
Average
13.78M
Median
Sep 2019
Cash from Investing (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 0.00 |
| HealthEquity Inc | -11.27M |
| Corvus Pharmaceuticals Inc | -2.318M |
| Oragenics Inc | -1.00M |
| MAIA Biotechnology Inc | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -15.77M |
| Free Cash Flow | -68.47M |
| Free Cash Flow Per Share (Quarterly) | -0.0675 |
| Free Cash Flow to Equity (Quarterly) | -16.81M |
| Free Cash Flow to Firm (Quarterly) | -16.81M |
| Free Cash Flow Yield | -21.04% |